Showing results (201-210 of 582) with videos related to
Sort By:
Pageof 59
Nucleic Acids Symposium Series (2004)|September 9, 2008
Synthesis and antiviral activity of novel derivatives of 2'-beta-C-methylcytidineJoanna Fogt, Piotr Januszczyk, Grzegorz Framski, et al.International Journal of Molecular Sciences|February 25, 2023
Insertion of an Amphipathic Linker in a Tetrapodal Tryptophan Derivative Leads to a Novel and Highly Potent Entry Inhibitor of Enterovirus A71 Clinical IsolatesOlaia Martí-Marí, Rana Abdelnabi, Dominique Schols, et al.The Journal of Antimicrobial Chemotherapy|August 9, 2020
Enhanced efficacy of endonuclease inhibitor baloxavir acid against orthobunyaviruses when used in combination with ribavirinSebastiaan Ter Horst, Yaiza Fernandez-Garcia, Marcella Bassetto, et al.International Journal of Molecular Sciences|June 26, 2025
Discovery of Small Molecules Targeting Norovirus 3CL Protease by Multi-Stage Virtual ScreeningZhongling Shi, Na Liu, Fabao Zhao, et al.European Journal of Medicinal Chemistry|November 5, 2016
In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicaseMarcella Bassetto, Pieter Leyssen, Johan Neyts, et al.Plos One|July 9, 2011
Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cellsMarijke M F Alen, Tine De Burghgraeve, Suzanne J F Kaptein, et al.RNA Biology|January 18, 2021
Identification of host factors binding to dengue and Zika virus subgenomic RNA by efficient yeast three-hybrid screens of the human ORFeomeSander Jansen, Enisa Smlatic, Daniëlle Copmans, et al.Antiviral Research|May 18, 2010
Antiviral strategies to control calicivirus infectionsJacques Rohayem, Mirko Bergmann, Julia Gebhardt, et al.Biochemical Pharmacology|June 14, 2015
Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cellsLeen Delang, Els Scheers, Mareike Grabner, et al.Antiviral Therapy|June 25, 2008
Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutantsSandra Carrouée-Durantel, David Durantel, Bettina Werle-Lapostolle, et al.Pageof 59